In the fall of 2014, Tufts University School of Medicine launched a Biopharma Program (Master of Science in Development and Regulation on Medicines and Devices) that was designed specifically to enhance career options through intensive training in disciplines that contribute to the development and regulation of human pharmaceuticals and medical devices. This specialized program met a need for structured, educational opportunities that had a focus on the fundamental concepts of therapeutic product development.
In the spring of 2016, the administration of the School of Medicine made the decision to no longer matriculate candidates to the Biopharma Program as of the fall of 2016. This decision was based on unexpected changes in the business environment and prospective students' desire for a more flexible program structure, which impacted the growth potential for the program.
Information about the program from 2014-2016 is available at these links:
For further information, contact the Program Director, Paul Beninger.